News

Filter

Valeant Pharma beats forecasts, turns in profit

07-08-2013

Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) announced second quarter financial…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

Valeant confirms plan to acquire Bausch & Lomb in a $8.7 billion transaction

28-05-2013

Following speculation ahead of the extended holiday weekend, acquisitive Canadian drugmaker Valeant Pharmaceuticals…

Bausch & LombMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

ISTA Pharma pleads guilty to federal felony charges in $33.5 million settlement; parent Bausch & Lomb a Valeant takeover target?

27-05-2013

US drugmaker ISTA Pharmaceuticals has pleaded guilty to conspiracy to introduce a misbranded drug into…

Bausch & LombISTA PharmaceuticalLegalMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalValeant PharmaceuticalsXibrom

COMPANY SPOTLIGHT

Menarini

Back to top